SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a fresh 52-week high ahead of the anticipated Q3 earnings report is driving attention, with traders focused on BRIUMVIs sales momentum and the possibility of an earnings beat. Buyout and short-squeeze speculation is also prominent, but remains unconfirmed.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is caught in a broader technology and semiconductor selloff after Intels weak outlook heightened concerns about PC demand and chip-sector growth, with traders also scrutinizing AI spending and elevated valuations ahead of AMDs earnings report. The community is split between expecting sympathy selling to reverse because Intels struggles could benefit AMD, and fearing further pressure if AI expectations reset.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy, with the November 22 target date and upper-limb function data driving speculation about approval. Bulls cite recent FDA rare-disease discussions, an unrelated DMD programs regulatory flexibility and Capricors launch-related job postings as encouraging signs, while skeptics stress that approval is uncertain and point to past FDA concerns and the risk of a CRL.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus BOT+BAL immunotherapy data in colorectal cancer dominate discussion, particularly published NEST Phase 2 results showing pathologic responses and no observed recurrences at follow-up. Bulls view the findings as promising, while skeptics question the small, nonrandomized studies and point to the need for Phase 3 validation, alongside concerns about dilution and management execution.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,155,828.93500734 in circulation. The last known price of Hedera is 0.07221819 USD and is up 4.74 over the last 24 hours. It is currently trading on 465 active market(s) with $92,347,671.42 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

HBARs sharp rally and elevated volume are being linked by traders to IBM-related cloud news and Hederas reported connections to NVIDIAs AI safety platform. Enthusiasm over enterprise and AI use cases is tempered by profit-taking and skepticism that the announcements will translate into meaningful adoption or token demand.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons earnings miss and heavy AI-infrastructure spending, which pushed free cash flow negative, sparked concern that returns may lag the investment. Traders debated that cash-burn risk against accelerating AWS growth, and many viewed the sharp initial selloff and subsequent rebound as an overreaction.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall during 2027 has fueled concerns about pricing and revenue, alongside CRMDs sharp selloff. Traders are divided over whether the warning signals lasting pressure or is a preliminary estimate overstated by the market, pointing to CMSs published rate and possible adoption gains as counterarguments.

Cameco Corp. engages in the provision of uranium. It operates through the following segments: Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Camecos Q3 report and narrower production guidance are driving the selloff, with traders criticizing the results as underwhelming and pointing to Cigar Lake operating setbacks. Some see the drop as justified by near-term execution concerns, while others argue rising uranium prices and long-term nuclear demand support the investment thesis.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the November 14 FDA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer, with traders weighing the Phase 3 results and recent positive biliary-cancer data against regulatory concerns, including the lack of statistically significant overall-survival results. Bulls see approval potential and broader promise for the drug, while skeptics stress that the decision remains uncertain and could hinge on FDA concerns about the trial population or manufacturing.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys stronger-than-expected quarterly results, supported by theme-park demand and improving streaming profitability, have fueled bullish interest and analyst optimism. Traders remain divided, with many welcoming the business momentum while questioning whether it can break the stock out of its long period of limited share-price gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jim Cramer warned that Wall Street could face further volatility next week as concerns about AI spending, major earnings reports, the midterm elections and the U.S. jobs report weigh on sentiment.   
Key events to watch: 
Monday: Apple reports earnings, with its nearly 40x P/E valuation leaving little room for disappointment. Cramer also expects strong results from Palantir. 
Tuesday: Midterm elections could affect data center construction amid growing political opposition. AMD reports, with Cramer expecting better results than Intel. Pfizer and Amgen also release earnings. Wednesday: CVS and McDonald&#39;s report, with attention on CVS&#39;s pharmacy benefit management business and McDonald&#39;s turnaround strategy. 
Thursday: Kimberly-Clark reports. Cramer remains bullish following its planned Kenvue merger and sees potential buying opportunities on weakness. 
Friday: The U.S. jobs report will provide further clues on employment, wage growth and inflation.  
$AAPL $PLTR $AMD $SPX  $IWM

Pauline kraus

wildcatbanker

Leonard Rosenbaum

SpartanTrades

Becky Downs

StockTwits Web

Apple Inc

Palantir Technologies Inc

S&P 500 Index

iShares Russell 2000 ETF

Jim Cramer warned that Wall Street could face further volatility next week as concerns about AI spending, major earnings reports, the midterm elections and the U.S. jobs report weigh on sentiment.   
Key events to watch: 
Monday: Apple reports earnings, with its nearly 40x P/E valuation leaving little room for disappointment. Cramer also expects strong results from Palantir. 
Tuesday: Midterm elections could affect data center construction amid growing political opposition. AMD reports, with Cramer expecting better results than Intel. Pfizer and Amgen also release earnings. Wednesday: CVS and McDonald's report, with attention on CVS's pharmacy benefit management business and McDonald's turnaround strategy. 
Thursday: Kimberly-Clark reports. Cramer remains bullish following its planned Kenvue merger and sees potential buying opportunities on weakness. 
Friday: The U.S. jobs report will provide further clues on employment, wage growth and inflation.  


Top Stock Alerts

@topstockalerts cramer. Really?  Even a blind squirrel gets the nut once.  I think the whales are testing revovery times to determine sentiment or they pulled out because of a solar storm/pre election revolution.

StockTwits For Android 

 cramer. Really?  Even a blind squirrel gets the nut once.  I think the whales are testing revovery times to determine sentiment or they pulled out because of a solar storm/pre election revolution.